Answers are grounded in this paper and cite their sources.
Case report reveals visual recovery after iOCT-guided subretinal rtPA delivery for traumatic submacular hemorrhage, highlighting a viable technique without dedicated commercial microinjectors.
PURPOSE: To report the management of traumatic submacular hemorrhage (SMH) in a highly myopic eye using early pars plana vitrectomy and low-dose subretinal recombinant tissue plasminogen activator (rtPA) delivered with a console-controlled micro-dosing system under microscope-integrated optical coherence tomography (iOCT) guidance. METHODS: A 36-year-old man with high myopia (-15.00 D) presented with acute traumatic SMH and severe visual loss. He underwent combined phacoemulsification and pars plana vitrectomy with internal limiting membrane peeling. Subretinal rtPA (25 μg/0.1 mL) was delivered through a 38-gauge cannula using a viscous fluid control-based injector assembled from standard sterile components. iOCT was used to confirm retinotomy position, subretinal placement, and bleb formation. Fluid-air exchange and 12% C3F8gas tamponade completed the procedure. RESULTS: The hemorrhage displaced progressively and resorbed over follow-up. Best-corrected visual acuity improved from counting fingers at presentation to 0.4 at 1 month and 0.7 at 3 months, remaining stable at 6 months. Optical coherence tomography showed restoration of foveal contour with persistent outer retinal disruption. No intraoperative or postoperative complications were observed. CONCLUSION: In this case, iOCT-guided console-controlled micro-dosing enabled controlled subretinal rtPA delivery and effective displacement of traumatic SMH using nonproprietary instrumentation. This workflow may be useful when dedicated commercial microinjectors are unavailable.
No takes yet. Share an insight, caveat, or question.
Marchese et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: